VALERIE CAIN: Open Payments
NPI 1861083305 · ELEANOR, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,311 in 91 payments from 12 companies in 2025. Trend: 2023 $869 · 2024 $1,457 · 2025 $1,311
Food & beverage: $1,311
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $568 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $216 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $117 |
| Novo Nordisk Inc | 5 | $88 |
| Echosens North America, Inc. | 1 | $76 |
| PFIZER INC. | 4 | $69 |
| Vanda Pharmaceuticals Inc. | 3 | $66 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Exact Sciences Corporation | 1 | $25 |
| Dexcom, Inc. | 1 | $21 |
Products named: VRAYLAR, CAPLYTA, QULIPTA, XIFAXAN, UBRELVY, Fibroscan, FANAPT, PREVNAR 20.
Industry payments across WV — which companies pay providers there.
